This text is a result of machine translation.
Shanghai to Launch Its First Direct Passenger Flight Route to a Central Asian Country in May
China’s E-bike Brands Going Global: A Review of 26 Leading Players
With the global e-bike market continuing to expand, Chinese e-bike companies are gradually shifting from being a manufacturing powerhouse to becoming a meaningful force in global competition. This article reviews a group of Chinese e-bike players and examines their overseas positioning and market entry paths—looking at how Chinese brands are securing a foothold in the next wave of globalization.
Dec 19, 2025 02:56 PM
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
Power Device Company Maplesemi Completes Series A+ Financing Round
Acoustic Technology Company Audfly Completes Series B Financing Round
Wicue Raised CNY 200 Mn in Series C+ Financing Round
Intelligent Industrial Drone and UAV Systems Developer I-KINGTEC Closed A Series C+ Financing Round
Alphamab Licenses Cancer Drug to Pathos AI in Deal Worth More Than US$2.2 Billion
Alphamab Oncology (康宁杰瑞生物制药) has licensed the overseas rights to its experimental cancer drug JSKN016 to US-based Pathos AI in a deal potentially worth more than US$2.2 billion, marking another major overseas licensing agreement for China’s rapidly expanding innovative-drug sector.
Yesterday 05:41 PM
Dajin Heavy Industry Secures CNY 1 Billion Bulk Carrier Order from Norwegian Shipowner
On August 5, 2026, Dajin Heavy Industry Co., Ltd. (大金重工股份有限公司) announced that its subsidiary, Tangshan Dajin Offshore Marine Engineering Co., Ltd. (唐山大金海工海洋工程有限公司), had signed contracts with a Norwegian shipowner to build two 211,000-deadweight-ton bulk carriers. The contracts are worth approximately CNY 1 billion, with the vessels scheduled for delivery in batches in 2029.
Yesterday 11:26 AM
Em-Data Technology Completed Strategic Financing Round
We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
Unpacking China | Key Chinese Firms to Watch This Week (26/07/2026-01/08/2026)
Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.
Aug 01, 2026 09:53 AM
Mabwell Signs GCC Licensing Deal with Saudi Arabia’s SVAX for Aflibercept Biosimilar
Mabwell (Shanghai) Bioscience Co., Ltd.(迈威(上海)生物科技股份有限公司)has entered into a licensing agreement with Saudi Arabian biopharmaceutical company SVAX Inc. covering its aflibercept biosimilar, 9MW0813, in the Gulf Cooperation Council market.
Jul 31, 2026 03:00 PM
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
ZD Medtech Raised Over CNY 100 Mn in Series B
Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn
Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A
Beyond Capital: Why Europe Needs Industrial Partners, Not Just Investors
Aug 04, 2026 11:21 AM
A Small Aircraft, a Bigger Bet: How China's Worthy Aero Plans to Scale Up
Jul 31, 2026 02:44 PM